These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 6734027)

  • 1. Stereoselective clearance and distribution of intravenous propranolol.
    Olanoff LS; Walle T; Walle UK; Cowart TD; Gaffney TE
    Clin Pharmacol Ther; 1984 Jun; 35(6):755-61. PubMed ID: 6734027
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stereoselective binding of propranolol to human plasma, alpha 1-acid glycoprotein, and albumin.
    Walle UK; Walle T; Bai SA; Olanoff LS
    Clin Pharmacol Ther; 1983 Dec; 34(6):718-23. PubMed ID: 6641085
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of food on the intravenous and oral dose kinetics of propranolol in the dog.
    Bai SA; Walle UK; Walle T
    J Pharmacokinet Biopharm; 1985 Jun; 13(3):229-41. PubMed ID: 4087163
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Food effects on propranolol systemic and oral clearance: support for a blood flow hypothesis.
    Olanoff LS; Walle T; Cowart TD; Walle UK; Oexmann MJ; Conradi EC
    Clin Pharmacol Ther; 1986 Oct; 40(4):408-14. PubMed ID: 3757404
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of age on the protein binding and disposition of propranolol stereoisomers.
    Lalonde RL; Tenero DM; Burlew BS; Herring VL; Bottorff MB
    Clin Pharmacol Ther; 1990 Apr; 47(4):447-55. PubMed ID: 2328552
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stereoselective oral bioavailability of (+/-)-propranolol in the dog. A GC-MS study using a stable isotope technique.
    Walle T; Walle UK
    Res Commun Chem Pathol Pharmacol; 1979 Mar; 23(3):453-64. PubMed ID: 461970
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stereoselective disposition of propranolol in rabbits. Role of presystemic organs and dose.
    Marier JF; Pichette V; du Souich P
    Drug Metab Dispos; 1998 Feb; 26(2):164-9. PubMed ID: 9456303
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stereoselective increase in propranolol bioavailability during chronic dosing in the dog.
    Bai SA; Wilson MJ; Walle UK; Walle T
    J Pharmacol Exp Ther; 1983 Nov; 227(2):360-4. PubMed ID: 6631718
    [TBL] [Abstract][Full Text] [Related]  

  • 9. No stereoselective first-pass hepatic extraction of propranolol.
    Jackman GP; McLean AJ; Jennings GL; Bobik A
    Clin Pharmacol Ther; 1981 Sep; 30(3):291-6. PubMed ID: 7273593
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics and metabolism of oral doses of a 4'-methylthio derivative of propranolol in man.
    Walle T; Walle UK; Cowart TD; Conradi EC; Gaffney TE
    Xenobiotica; 1990 Mar; 20(3):321-31. PubMed ID: 2336841
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stereochemistry of tissue distribution of racemic propranolol in the dog.
    Walle UK; Thibodeaux H; Privitera PJ; Walle T
    Chirality; 1989; 1(3):192-6. PubMed ID: 2642048
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interactions of phenobarbital with propranolol in the dog. 2. Bioavailability, metabolism and pharmacokinetics.
    Vu VT; Bai SA; Abramson FP
    J Pharmacol Exp Ther; 1983 Jan; 224(1):55-61. PubMed ID: 6848749
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of halothane on drug disposition: contribution of changes in intrinsic drug metabolizing capacity and hepatic blood flow.
    Reilly CS; Wood AJ; Koshakji RP; Wood M
    Anesthesiology; 1985 Jul; 63(1):70-6. PubMed ID: 4014773
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of diltiazem on the disposition and metabolism of the enantiomers of propranolol in the dog during multiple oral dosing.
    Lankford SM; Maskasame C; Bai SA
    Drug Metab Dispos; 1994; 22(5):776-87. PubMed ID: 7835231
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of calcium channel blockers on the pharmacokinetics of propranolol stereoisomers.
    Hunt BA; Bottorff MB; Herring VL; Self TH; Lalonde RL
    Clin Pharmacol Ther; 1990 May; 47(5):584-91. PubMed ID: 2344707
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rectal and intravenous propranolol infusion to steady state: kinetics and beta-receptor blockade.
    de Leede LG; Hug CC; de Lange S; de Boer AG; Breimer DD
    Clin Pharmacol Ther; 1984 Feb; 35(2):148-55. PubMed ID: 6319066
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of thyroid dysfunction on propranolol kinetics.
    Riddell JG; Neill JD; Kelly JG; McDevitt DG
    Clin Pharmacol Ther; 1980 Nov; 28(5):565-74. PubMed ID: 7438675
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased clearance of propranolol and theophylline by high-protein compared with high-carbohydrate diet.
    Fagan TC; Walle T; Oexmann MJ; Walle UK; Bai SA; Gaffney TE
    Clin Pharmacol Ther; 1987 Apr; 41(4):402-6. PubMed ID: 3829577
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Age and propranolol stereoselective disposition in humans.
    Colangelo PM; Blouin RA; Steinmetz JE; McNamara PJ; DeMaria AN; Wedlund PJ
    Clin Pharmacol Ther; 1992 May; 51(5):489-94. PubMed ID: 1587061
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differences in stereoselective disposition of propranolol do not explain sensitivity differences between white and Chinese subjects: correlation between the clearance of (-)- and (+)-propranolol.
    Zhou HH; Wood AJ
    Clin Pharmacol Ther; 1990 Jun; 47(6):719-23. PubMed ID: 2357866
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.